• Packed Red Cells type: O negative
  • Packed red blood cells replace lost haemoglobin with the intent of improving O2 carrying capacity of the circulation
Treatment of haemorrhagic shock involves maintaining blood pressure and tissue perfusion until the bleeding is controlled
  • Patients symptomatic of reduced oxygen-carrying capacity secondary to exsanguination.
  • Once blood is opened or “spiked”, the blood components will expire 4 hours after opening and must be infused in this time
  • Presence of medical directive / advanced directive / alert card expressing that they refuse blood under any circumstances (e.g.: Jehovah’s Witnesses or non-consenting patient)
  • A temperature rise to >38°C should result in immediate cessation of the transfusion
  • Exercise caution in hypothermic patient with rise >1°C who have commenced active warming
 Precautions / Notes
  • Routine warming of blood is not necessary.
  • Severe reactions are uncommon, however they are most likely to occur within the first 15 minutes/50mls of each unit and patients should be closely observed during this period especially for signs of fever and loin pain or discomfort.
  • Blood transfusion should never be a substitute for meticulous haemorrhage control.
  • No medications or solutions (except 0.9% sodium chloride solution) should be added to the blood bag or co-administered through the same giving set.
  • As a minimum; the vital signs of temperature, pulse, respiration rate and blood pressure prior to commencing infusion and every 15 minutes thereafter.
 Weight-based Calculations
Cefazolin for fractures/prophylaxis
Presentation: /mL
Calculated dose:  in

Critical Care
Paediatric Patients
  • For patients <12yrs: First obtain ASMA approval. Administer 10ml/kg, maximum 1 unit.
  • If bleeding is the obvious cause, is not fully controlled and there is evidence of inadequate organ perfusion: administer blood as first line agent, as crystalloid solution will only further dilute the clotting factors and platelets.
  • If the cause of loss of consciousness / hypotension / tachycardia is unclear, then administering IV fluids as first line agent may be more appropriate.
  • Once dose achieved, leave Packed Red Cells in situ if less than 3 hours from use.
  • Check external blood box thermometer reading within range of 2.5 - 6°C. If not: do not use.
  • Check internal data logger ensure temp within 2.5 - 6°C. If not: do not use.
  • Check blood product details (ensure O negative)
  • Check expiry date and time of blood
  • All attempts should be made to maintain patient momentum to definitive care
  • Obtain verbal consent from patient where possible including discussion of proposed red cell transfusion risks and benefits of transfusion, including risks of doing nothing. Document verbal consent in ePCR
  • Check that the integrity of the blood product is confirmed. No leaks at ports / packing seams, no evidence of haemolysis (unusual discolouration or turbidity), or large clots.  If identified / if in doubt: do not transfuse.
  • Ensure large bore IV access; take blood for laboratory (pink vial).
  • Transfuse through filtered IV giving set approved for blood administration (170-20um Filter) to remove clots and aggregates. Ensure primed with normal saline.
  • If required, transfuse through the MEQU Fluid & Blood Warmer.
  • Ascertain base line observations and document accordingly.
  • Monitor patient for adverse effects.
  • If any concerns arise from transfusion reaction:
    • Cease transfusion and manage appropriately.
    • Report all transfusion reactions to receiving medical team and ASMA post case.
    • Document in ePCR.
    • Should a transfusion reaction have taken place, keep the blood bag and handover to medical team.
  • Incomplete transfusion bags to be left with medical staff / nursing staff at receiving hospital.
  • Unused units to remain in Pelican case and returned to HEM base if temp remains within range 2.5 - 6°C
  • Complete blood issuing paperwork.
 Special Considerations
  • Febrile (non-haemolytic) transfusion reaction.
  • Acute and delayed haemolytic reaction.
  • Allergy / Anaphylaxis.
  • Transfusion-related circulatory overload (TACO).
Approximately 260ml - 300ml bag for intravenous administration
Current mode:
Extended Care:
Colour assist:

Kwan, I. et al., The Cochrane Library, 2000

Document Control

Clinical Services

Responsible Manager
Head of Clinical Services


Issue Date

Expiry Date

Clinical Resources Website

St John Ambulance Western Australia Ltd (ABN 55 028 468 715) (St John WA) operates ambulance and other pre-hospital clinical services. St John WA’s Clinical Resources, including its Clinical Practice Guidelines (Clinical Resources), are intended for use by credentialed St John WA staff and volunteers when providing clinical care to patients for or on behalf of St John WA, within the St John WA Clinical Governance Framework, and only to the extent of the clinician’s authority to practice.

Other users – Terms of Use

The content of the St John WA Clinical Resources is provided for information purposes only and is not intended to serve as health, medical or treatment advice. Any user of this website agrees to be bound by these Terms of Use in their use of the Clinical Resources.

St John WA does not represent or warrant (whether express, implied, statutory, or otherwise) that the content of the Clinical Resources is accurate, reliable, up-to-date, complete or that the information contained is suitable for your needs or for any particular purpose. You are responsible for assessing whether the information is accurate, reliable, up-to-date, authentic, relevant, or complete and where appropriate, seek independent professional advice.

St John WA expressly prohibits use of these Clinical Resources to guide clinical care of patients by organisations external to St John WA, except where these organisations have been directly engaged by St John WA to provide services. Any use of the Clinical Resources, with St John WA approval, must attribute St John WA as the creator of the Clinical Resources and include the copyright notice and (where reasonably practicable) provide a URL/hyperlink to the St John WA Clinical Resources website. 

No permission or licence is granted to reproduce, make commercial use of, adapt, modify or create derivative works from these Clinical Resources. For permissions beyond the scope of these Terms of Use, including a commercial licence, please contact medservices@stjohnambulance.com.au

Where links are provided to resources on external websites, St John WA:

  • Gives no assurances about the quality, accuracy or relevance of material on any linked site;
  • Accepts no legal responsibility regarding the accuracy and reliability of external material; and
  • Does not endorse any material, associated organisation, product or service on other sites.

Your use of any external website is governed by the terms of that website, including any authorisation, requirement or licence for use of the material on that website.

To the maximum extent permitted by law, St John WA excludes liability (including liability in negligence) for any direct, special, indirect, incidental, consequential, punitive, exemplary or other loss, cost, damage or expense arising out of, or in connection with, use or reliance on the Clinical Resources (including without limitation any interference with or damage to a user’s computer, device, software or data occurring in connection with such use).


Please read this cookie policy carefully before using Clinical Resources from St John WA.

The cookies used on this site are small and completely anonymous pieces of information and are stored on your computer or mobile device. The data that the cookies contain identify your user preferences (such as your preferred text size, scope / skill level preference and Colour Assist mode, among other user settings) so that they can be recalled the next time that you visit a page within Clinical Resources. These cookies are necessary to offer you the best and most efficient possible experience when accessing and navigating through our website and using its features. These cookies do not collect or send analytical information back to St John WA.

Clinical Resources does integrate with Google Analytics and any cookies associated with this service enable us (and third-party services) to collect aggregated data for statistical purposes on how our visitors use this website. These cookies do not contain personal information such as names and email addresses and are used to help us improve your user experience of the website.

If you want to restrict or block the cookies that are set by our website, you can do so through your browser setting. Alternatively, you can visit www.internetcookies.com, which contains comprehensive information on how to do this on a wide variety of browsers and devices. You will find general information about cookies and details on how to delete cookies from your device. If you have any questions about this policy or our use of cookies, please contact us.

St John Ambulance Western Australia Ltd © Copyright 2020, All Rights Reserved

Terms of Use | Privacy Policy | Copyright Statement & Disclaimer